207 related articles for article (PubMed ID: 24284410)
1. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination.
Nguyen TH; Vu MH; Nguyen VC; Nguyen LH; Toda K; Nguyen TN; Dao S; Wannemuehler KA; Hennessey KA
Vaccine; 2014 Jan; 32(2):217-22. PubMed ID: 24284410
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal.
Upreti SR; Gurung S; Patel M; Dixit SM; Krause LK; Shakya G; Wannemuehler K; Rajbhandari R; Bohara R; Schluter WW
Vaccine; 2014 Jul; 32(34):4304-9. PubMed ID: 24951865
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Chronic Hepatitis B Virus Infection among Children in Haiti, 2017.
Childs L; Adrien P; Minta AA; François J; Phaïmyr Jn Charles N; Blot V; Rey-Benito G; Vanden Eng JL; Tohme RA
Am J Trop Med Hyg; 2019 Jul; 101(1):214-219. PubMed ID: 31115298
[TBL] [Abstract][Full Text] [Related]
6. Sibling status, home birth, tattoos and stitches are risk factors for chronic hepatitis B virus infection in Senegalese children: A cross-sectional survey.
Périères L; Protopopescu C; Lo G; Marcellin F; Ba EH; Coste M; Touré Kane C; Diallo A; Sokhna C; Boyer S;
J Viral Hepat; 2021 Nov; 28(11):1515-1525. PubMed ID: 34355470
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
Minta AA; Silva MWT; Shrestha A; de Quiroz-Castro M; Tohme RA; Quimson ME; Jiz MA; Woodring J
Vaccine; 2021 Apr; 39(14):1982-1989. PubMed ID: 33712351
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
Garcia D; Porras A; Rico Mendoza A; Alvis N; Navas MC; De La Hoz F; De Neira M; Osorio E; Valderrama JF
Vaccine; 2018 May; 36(19):2721-2726. PubMed ID: 29609968
[TBL] [Abstract][Full Text] [Related]
11. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
13. Low Level of Hepatitis B Virus Infection in Children 20 Years After Initiation of Infant Vaccination Program in Wallis and Futuna.
Pezzoli L; Mathelin JP; Hennessey K; Eswara-Aratchige P; Valiakolleri J; Kim SH
Am J Trop Med Hyg; 2017 Mar; 96(3):715-719. PubMed ID: 28070010
[TBL] [Abstract][Full Text] [Related]
14. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
Bialek SR; Helgenberger L; Fischer GE; Bower WA; Konelios M; Chaine JP; Armstrong G; Williams IT; Bell BP
Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
[TBL] [Abstract][Full Text] [Related]
15. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
Childs L; Roesel S; Tohme RA
Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
Khetsuriani N; Zaika O; Chitadze N; Slobodianyk L; Allahverdiyeva V; O'Connor P; Huseynov S
Vaccine; 2021 Mar; 39(10):1485-1492. PubMed ID: 33583671
[TBL] [Abstract][Full Text] [Related]
17. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen seroprevalence among children in Papua New Guinea, 2012-2013.
Kitau R; Datta SS; Patel MK; Hennessey K; Wannemuehler K; Sui G; Lagani W
Am J Trop Med Hyg; 2015 Mar; 92(3):501-6. PubMed ID: 25582692
[TBL] [Abstract][Full Text] [Related]
19. The status of hepatitis B control in the African region.
Breakwell L; Tevi-Benissan C; Childs L; Mihigo R; Tohme R
Pan Afr Med J; 2017; 27(Suppl 3):17. PubMed ID: 29296152
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.
Cui F; Li L; Hadler SC; Wang F; Zheng H; Chen Y; Gong X; Hutin YJ; Cairns KL; Liang X; Yang W
Vaccine; 2010 Aug; 28(37):5973-8. PubMed ID: 20637773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
